Diana Isaacs, PharmD, chair of a recent Institute for Value-Based Medicine® event hosted in conjunction with Cleveland Clinic, details the up-and-coming therapies impacting the scope of treatment in diabetes, obesity, and cardiometabolic health, as well as their associated challenges.
Related Keywords
Diana Isaacs , Institute For Value , Cardiometabolic Health , Cleveland Clinic , Value Based Medicine , Glp 1 , Diabetes , Obesity ,
comparemela.com © 2020. All Rights Reserved.